nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—Lenalidomide—hematologic cancer	0.124	0.209	CbGbCtD
Ketorolac—PTGS2—Thalidomide—hematologic cancer	0.0664	0.111	CbGbCtD
Ketorolac—PTGS1—Bortezomib—hematologic cancer	0.0644	0.108	CbGbCtD
Ketorolac—PTGS1—Thalidomide—hematologic cancer	0.0561	0.0941	CbGbCtD
Ketorolac—PTGS1—Ifosfamide—hematologic cancer	0.0494	0.0828	CbGbCtD
Ketorolac—PTGS1—Imatinib—hematologic cancer	0.0471	0.0791	CbGbCtD
Ketorolac—PTGS2—Triamcinolone—hematologic cancer	0.046	0.0772	CbGbCtD
Ketorolac—PTGS2—Betamethasone—hematologic cancer	0.0395	0.0662	CbGbCtD
Ketorolac—PTGS2—Cisplatin—hematologic cancer	0.0284	0.0477	CbGbCtD
Ketorolac—PTGS2—Etoposide—hematologic cancer	0.0279	0.0469	CbGbCtD
Ketorolac—PTGS1—Etoposide—hematologic cancer	0.0236	0.0396	CbGbCtD
Ketorolac—PTGS2—Dexamethasone—hematologic cancer	0.023	0.0385	CbGbCtD
Ketorolac—PTGS2—ovarian follicle—hematologic cancer	0.00657	0.556	CbGeAlD
Ketorolac—PTGS1—hematopoietic system—hematologic cancer	0.00083	0.0702	CbGeAlD
Ketorolac—PTGS2—hematopoietic system—hematologic cancer	0.000793	0.0671	CbGeAlD
Ketorolac—Suprofen—UGT1A1—hematologic cancer	0.000769	0.462	CrCbGaD
Ketorolac—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000635	0.209	CbGdCrCtD
Ketorolac—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000635	0.209	CbGdCrCtD
Ketorolac—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000621	0.205	CbGdCrCtD
Ketorolac—Tolmetin—MPO—hematologic cancer	0.000589	0.354	CrCbGaD
Ketorolac—PTGS1—blood—hematologic cancer	0.00055	0.0465	CbGeAlD
Ketorolac—PTGS2—blood—hematologic cancer	0.000525	0.0445	CbGeAlD
Ketorolac—PTGS2—bone marrow—hematologic cancer	0.000508	0.043	CbGeAlD
Ketorolac—PTGS1—lung—hematologic cancer	0.000482	0.0408	CbGeAlD
Ketorolac—PTGS2—lung—hematologic cancer	0.000461	0.039	CbGeAlD
Ketorolac—PTGS1—testis—hematologic cancer	0.000455	0.0385	CbGeAlD
Ketorolac—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000383	0.126	CbGdCrCtD
Ketorolac—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000383	0.126	CbGdCrCtD
Ketorolac—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000375	0.124	CbGdCrCtD
Ketorolac—PTGS1—lymph node—hematologic cancer	0.00033	0.0279	CbGeAlD
Ketorolac—PTGS2—lymph node—hematologic cancer	0.000315	0.0267	CbGeAlD
Ketorolac—Mebendazole—ABCB1—hematologic cancer	0.000212	0.127	CrCbGaD
Ketorolac—Ketoprofen—ALB—hematologic cancer	9.59e-05	0.0576	CrCbGaD
Ketorolac—PTGS2—Disease—PSIP1—hematologic cancer	4.21e-05	0.000674	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PC—hematologic cancer	4.21e-05	0.000674	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL6—hematologic cancer	4.19e-05	0.000671	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	4.13e-05	0.000661	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—TNF—hematologic cancer	4.12e-05	0.00066	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	4.12e-05	0.000659	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SLC35B2—hematologic cancer	4.07e-05	0.000651	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HDAC10—hematologic cancer	4.07e-05	0.000651	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	4.03e-05	0.000645	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	4.01e-05	0.000642	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HDC—hematologic cancer	4e-05	0.000641	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—MTAP—hematologic cancer	3.92e-05	0.000628	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	3.83e-05	0.000613	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	3.73e-05	0.000598	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CDA—hematologic cancer	3.66e-05	0.000586	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	3.64e-05	0.000583	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—HRAS—hematologic cancer	3.61e-05	0.000578	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MAPK3—hematologic cancer	3.6e-05	0.000576	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PC—hematologic cancer	3.53e-05	0.000564	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MYC—hematologic cancer	3.5e-05	0.00056	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—FHL2—hematologic cancer	3.5e-05	0.00056	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TGFB1—hematologic cancer	3.49e-05	0.000559	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	3.46e-05	0.000554	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AGRN—hematologic cancer	3.43e-05	0.000549	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	3.41e-05	0.000546	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC35B2—hematologic cancer	3.4e-05	0.000545	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GBA—hematologic cancer	3.4e-05	0.000545	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL6—hematologic cancer	3.33e-05	0.000533	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TNF—hematologic cancer	3.26e-05	0.000522	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HMMR—hematologic cancer	3.25e-05	0.00052	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—IDH2—hematologic cancer	3.25e-05	0.00052	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SNCA—hematologic cancer	3.25e-05	0.00052	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AGRN—hematologic cancer	3.25e-05	0.00052	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPLP1—hematologic cancer	3.25e-05	0.00052	CbGpPWpGaD
Ketorolac—PTGS2—Disease—LEF1—hematologic cancer	3.13e-05	0.000502	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—MTAP—hematologic cancer	3.11e-05	0.000499	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	3.11e-05	0.000498	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HMMR—hematologic cancer	3.08e-05	0.000493	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.06e-05	0.000491	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ARNTL—hematologic cancer	3.06e-05	0.000489	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	3.05e-05	0.000488	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CA9—hematologic cancer	2.97e-05	0.000476	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ACP5—hematologic cancer	2.97e-05	0.000476	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	2.97e-05	0.000475	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	2.96e-05	0.000474	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NCOR2—hematologic cancer	2.93e-05	0.00047	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ELL—hematologic cancer	2.9e-05	0.000464	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TP53—hematologic cancer	2.87e-05	0.00046	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	2.87e-05	0.00046	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	2.86e-05	0.000459	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ACP5—hematologic cancer	2.82e-05	0.000451	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	2.8e-05	0.000449	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—IDH1—hematologic cancer	2.79e-05	0.000448	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NCOR2—hematologic cancer	2.78e-05	0.000445	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—FHL2—hematologic cancer	2.78e-05	0.000444	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ABCC3—hematologic cancer	2.76e-05	0.000443	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTO1—hematologic cancer	2.76e-05	0.000443	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—TXN—hematologic cancer	2.76e-05	0.000443	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	2.73e-05	0.000437	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AGRN—hematologic cancer	2.72e-05	0.000436	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SPHK1—hematologic cancer	2.7e-05	0.000433	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	2.66e-05	0.000425	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IDH1—hematologic cancer	2.65e-05	0.000424	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL6—hematologic cancer	2.63e-05	0.000421	CbGpPWpGaD
Ketorolac—PTGS2—Disease—GSTO1—hematologic cancer	2.62e-05	0.000419	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—UGT1A1—hematologic cancer	2.6e-05	0.000416	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	2.59e-05	0.000414	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—IDH2—hematologic cancer	2.58e-05	0.000413	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HMMR—hematologic cancer	2.58e-05	0.000413	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AGO2—hematologic cancer	2.56e-05	0.000411	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HDAC9—hematologic cancer	2.54e-05	0.000406	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CRABP1—hematologic cancer	2.53e-05	0.000405	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLC22A1—hematologic cancer	2.53e-05	0.000405	CbGpPWpGaD
Ketorolac—PTGS2—Disease—H3F3B—hematologic cancer	2.51e-05	0.000402	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALOX5—hematologic cancer	2.46e-05	0.000394	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	2.45e-05	0.000392	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.43e-05	0.00039	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ARNTL—hematologic cancer	2.43e-05	0.000388	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NPM1—hematologic cancer	2.42e-05	0.000387	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NUP98—hematologic cancer	2.39e-05	0.000382	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.38e-05	0.000381	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.37e-05	0.00038	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CA9—hematologic cancer	2.36e-05	0.000378	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ACP5—hematologic cancer	2.36e-05	0.000378	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NCOR2—hematologic cancer	2.33e-05	0.000373	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ADCY7—hematologic cancer	2.32e-05	0.000371	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NCOA3—hematologic cancer	2.32e-05	0.000371	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGF19—hematologic cancer	2.32e-05	0.000371	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NUP214—hematologic cancer	2.3e-05	0.000368	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPS14—hematologic cancer	2.3e-05	0.000368	CbGpPWpGaD
Ketorolac—PTGS2—Disease—DKK1—hematologic cancer	2.28e-05	0.000365	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.28e-05	0.000364	CbGpPWpGaD
Ketorolac—PTGS2—Disease—STAT5B—hematologic cancer	2.26e-05	0.000362	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NUP98—hematologic cancer	2.26e-05	0.000362	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—MTR—hematologic cancer	2.25e-05	0.000361	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ABCG2—hematologic cancer	2.25e-05	0.000361	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—IDH1—hematologic cancer	2.22e-05	0.000355	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.22e-05	0.000355	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CST3—hematologic cancer	2.21e-05	0.000354	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ENO2—hematologic cancer	2.21e-05	0.000354	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.2e-05	0.000352	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ADCY7—hematologic cancer	2.2e-05	0.000352	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTO1—hematologic cancer	2.19e-05	0.000351	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ABCC3—hematologic cancer	2.19e-05	0.000351	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TXN—hematologic cancer	2.19e-05	0.000351	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NUP214—hematologic cancer	2.18e-05	0.000349	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SPHK1—hematologic cancer	2.15e-05	0.000344	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTT1—hematologic cancer	2.14e-05	0.000343	CbGpPWpGaD
Ketorolac—PTGS2—Disease—XIAP—hematologic cancer	2.14e-05	0.000342	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MTR—hematologic cancer	2.14e-05	0.000342	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.11e-05	0.000338	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SDC1—hematologic cancer	2.09e-05	0.000335	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ENO2—hematologic cancer	2.09e-05	0.000335	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SMARCA4—hematologic cancer	2.08e-05	0.000333	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—UGT1A1—hematologic cancer	2.06e-05	0.00033	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.02e-05	0.000324	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC22A1—hematologic cancer	2.01e-05	0.000321	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CRABP1—hematologic cancer	2.01e-05	0.000321	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2e-05	0.00032	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SDC1—hematologic cancer	1.99e-05	0.000318	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.97e-05	0.000316	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALOX5—hematologic cancer	1.96e-05	0.000313	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.96e-05	0.000313	CbGpPWpGaD
Ketorolac—PTGS2—Disease—LCK—hematologic cancer	1.92e-05	0.000308	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NUP98—hematologic cancer	1.89e-05	0.000303	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.89e-05	0.000303	CbGpPWpGaD
Ketorolac—PTGS2—Disease—H3F3A—hematologic cancer	1.88e-05	0.000302	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ADCY7—hematologic cancer	1.84e-05	0.000294	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NCOA3—hematologic cancer	1.84e-05	0.000294	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PRKCZ—hematologic cancer	1.83e-05	0.000293	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NUP214—hematologic cancer	1.83e-05	0.000292	CbGpPWpGaD
Ketorolac—Flushing—Doxorubicin—hematologic cancer	1.81e-05	5.58e-05	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—hematologic cancer	1.81e-05	5.58e-05	CcSEcCtD
Ketorolac—Flatulence—Epirubicin—hematologic cancer	1.81e-05	5.58e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.81e-05	0.000289	CbGpPWpGaD
Ketorolac—Tension—Epirubicin—hematologic cancer	1.8e-05	5.55e-05	CcSEcCtD
Ketorolac—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.8e-05	5.54e-05	CcSEcCtD
Ketorolac—Gastrointestinal pain—Betamethasone—hematologic cancer	1.8e-05	5.54e-05	CcSEcCtD
Ketorolac—Dysgeusia—Epirubicin—hematologic cancer	1.8e-05	5.54e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—CALR—hematologic cancer	1.8e-05	0.000288	CbGpPWpGaD
Ketorolac—Hypersensitivity—Triamcinolone—hematologic cancer	1.79e-05	5.51e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—MTR—hematologic cancer	1.79e-05	0.000286	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ABCG2—hematologic cancer	1.79e-05	0.000286	CbGpPWpGaD
Ketorolac—Nervousness—Epirubicin—hematologic cancer	1.79e-05	5.5e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—NQO1—hematologic cancer	1.78e-05	0.000285	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CD44—hematologic cancer	1.78e-05	0.000285	CbGpPWpGaD
Ketorolac—Back pain—Epirubicin—hematologic cancer	1.78e-05	5.47e-05	CcSEcCtD
Ketorolac—Angiopathy—Doxorubicin—hematologic cancer	1.77e-05	5.46e-05	CcSEcCtD
Ketorolac—Malaise—Methotrexate—hematologic cancer	1.77e-05	5.45e-05	CcSEcCtD
Ketorolac—Dizziness—Etoposide—hematologic cancer	1.77e-05	5.45e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—PARP1—hematologic cancer	1.77e-05	0.000283	CbGpPWpGaD
Ketorolac—Immune system disorder—Doxorubicin—hematologic cancer	1.77e-05	5.43e-05	CcSEcCtD
Ketorolac—Vertigo—Methotrexate—hematologic cancer	1.77e-05	5.43e-05	CcSEcCtD
Ketorolac—Mediastinal disorder—Doxorubicin—hematologic cancer	1.76e-05	5.42e-05	CcSEcCtD
Ketorolac—Leukopenia—Methotrexate—hematologic cancer	1.76e-05	5.41e-05	CcSEcCtD
Ketorolac—Chills—Doxorubicin—hematologic cancer	1.75e-05	5.4e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—ENO2—hematologic cancer	1.75e-05	0.000281	CbGpPWpGaD
Ketorolac—Urticaria—Betamethasone—hematologic cancer	1.75e-05	5.39e-05	CcSEcCtD
Ketorolac—Urticaria—Dexamethasone—hematologic cancer	1.75e-05	5.39e-05	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.75e-05	5.38e-05	CcSEcCtD
Ketorolac—Dizziness—Prednisolone—hematologic cancer	1.75e-05	5.37e-05	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—hematologic cancer	1.75e-05	5.37e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.74e-05	0.000279	CbGpPWpGaD
Ketorolac—Asthenia—Triamcinolone—hematologic cancer	1.74e-05	5.36e-05	CcSEcCtD
Ketorolac—Body temperature increased—Betamethasone—hematologic cancer	1.74e-05	5.36e-05	CcSEcCtD
Ketorolac—Abdominal pain—Dexamethasone—hematologic cancer	1.74e-05	5.36e-05	CcSEcCtD
Ketorolac—Abdominal pain—Betamethasone—hematologic cancer	1.74e-05	5.36e-05	CcSEcCtD
Ketorolac—Body temperature increased—Dexamethasone—hematologic cancer	1.74e-05	5.36e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—FBXW7—hematologic cancer	1.74e-05	0.000279	CbGpPWpGaD
Ketorolac—Nausea—Cisplatin—hematologic cancer	1.74e-05	5.34e-05	CcSEcCtD
Ketorolac—Insomnia—Prednisone—hematologic cancer	1.74e-05	5.34e-05	CcSEcCtD
Ketorolac—Vision blurred—Epirubicin—hematologic cancer	1.73e-05	5.33e-05	CcSEcCtD
Ketorolac—Alopecia—Doxorubicin—hematologic cancer	1.73e-05	5.31e-05	CcSEcCtD
Ketorolac—Paraesthesia—Prednisone—hematologic cancer	1.72e-05	5.3e-05	CcSEcCtD
Ketorolac—Pruritus—Triamcinolone—hematologic cancer	1.72e-05	5.29e-05	CcSEcCtD
Ketorolac—Cough—Methotrexate—hematologic cancer	1.72e-05	5.28e-05	CcSEcCtD
Ketorolac—Mental disorder—Doxorubicin—hematologic cancer	1.71e-05	5.27e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—HDAC2—hematologic cancer	1.71e-05	0.000273	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CXCR4—hematologic cancer	1.71e-05	0.000273	CbGpPWpGaD
Ketorolac—Ill-defined disorder—Epirubicin—hematologic cancer	1.71e-05	5.25e-05	CcSEcCtD
Ketorolac—Convulsion—Methotrexate—hematologic cancer	1.7e-05	5.24e-05	CcSEcCtD
Ketorolac—Vomiting—Etoposide—hematologic cancer	1.7e-05	5.24e-05	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—hematologic cancer	1.7e-05	5.24e-05	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—hematologic cancer	1.7e-05	5.24e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—GSTT1—hematologic cancer	1.7e-05	0.000272	CbGpPWpGaD
Ketorolac—Anaemia—Epirubicin—hematologic cancer	1.7e-05	5.23e-05	CcSEcCtD
Ketorolac—Agitation—Epirubicin—hematologic cancer	1.69e-05	5.2e-05	CcSEcCtD
Ketorolac—Dyspepsia—Prednisone—hematologic cancer	1.69e-05	5.2e-05	CcSEcCtD
Ketorolac—Rash—Etoposide—hematologic cancer	1.69e-05	5.19e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—CD44—hematologic cancer	1.69e-05	0.00027	CbGpPWpGaD
Ketorolac—Dermatitis—Etoposide—hematologic cancer	1.69e-05	5.19e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CYCS—hematologic cancer	1.69e-05	0.00027	CbGpPWpGaD
Ketorolac—Headache—Etoposide—hematologic cancer	1.68e-05	5.16e-05	CcSEcCtD
Ketorolac—Flatulence—Doxorubicin—hematologic cancer	1.68e-05	5.16e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.68e-05	0.000268	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HSP90AA1—hematologic cancer	1.67e-05	0.000268	CbGpPWpGaD
Ketorolac—Myalgia—Methotrexate—hematologic cancer	1.67e-05	5.15e-05	CcSEcCtD
Ketorolac—Arthralgia—Methotrexate—hematologic cancer	1.67e-05	5.15e-05	CcSEcCtD
Ketorolac—Chest pain—Methotrexate—hematologic cancer	1.67e-05	5.15e-05	CcSEcCtD
Ketorolac—Tension—Doxorubicin—hematologic cancer	1.67e-05	5.14e-05	CcSEcCtD
Ketorolac—Decreased appetite—Prednisone—hematologic cancer	1.67e-05	5.13e-05	CcSEcCtD
Ketorolac—Dysgeusia—Doxorubicin—hematologic cancer	1.67e-05	5.13e-05	CcSEcCtD
Ketorolac—Rash—Prednisolone—hematologic cancer	1.67e-05	5.12e-05	CcSEcCtD
Ketorolac—Dermatitis—Prednisolone—hematologic cancer	1.66e-05	5.12e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—CBL—hematologic cancer	1.66e-05	0.000266	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SDC1—hematologic cancer	1.66e-05	0.000266	CbGpPWpGaD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.66e-05	5.11e-05	CcSEcCtD
Ketorolac—Malaise—Epirubicin—hematologic cancer	1.66e-05	5.1e-05	CcSEcCtD
Ketorolac—Fatigue—Prednisone—hematologic cancer	1.65e-05	5.09e-05	CcSEcCtD
Ketorolac—Headache—Prednisolone—hematologic cancer	1.65e-05	5.09e-05	CcSEcCtD
Ketorolac—Discomfort—Methotrexate—hematologic cancer	1.65e-05	5.09e-05	CcSEcCtD
Ketorolac—Nervousness—Doxorubicin—hematologic cancer	1.65e-05	5.09e-05	CcSEcCtD
Ketorolac—Vertigo—Epirubicin—hematologic cancer	1.65e-05	5.08e-05	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.65e-05	0.000264	CbGpPWpGaD
Ketorolac—Syncope—Epirubicin—hematologic cancer	1.65e-05	5.07e-05	CcSEcCtD
Ketorolac—Leukopenia—Epirubicin—hematologic cancer	1.65e-05	5.07e-05	CcSEcCtD
Ketorolac—Back pain—Doxorubicin—hematologic cancer	1.65e-05	5.06e-05	CcSEcCtD
Ketorolac—Constipation—Prednisone—hematologic cancer	1.64e-05	5.05e-05	CcSEcCtD
Ketorolac—Palpitations—Epirubicin—hematologic cancer	1.63e-05	5e-05	CcSEcCtD
Ketorolac—Confusional state—Methotrexate—hematologic cancer	1.62e-05	4.98e-05	CcSEcCtD
Ketorolac—Loss of consciousness—Epirubicin—hematologic cancer	1.62e-05	4.97e-05	CcSEcCtD
Ketorolac—Dizziness—Triamcinolone—hematologic cancer	1.61e-05	4.94e-05	CcSEcCtD
Ketorolac—Cough—Epirubicin—hematologic cancer	1.61e-05	4.94e-05	CcSEcCtD
Ketorolac—Anaphylactic shock—Methotrexate—hematologic cancer	1.6e-05	4.93e-05	CcSEcCtD
Ketorolac—Vision blurred—Doxorubicin—hematologic cancer	1.6e-05	4.93e-05	CcSEcCtD
Ketorolac—Convulsion—Epirubicin—hematologic cancer	1.59e-05	4.9e-05	CcSEcCtD
Ketorolac—Infection—Methotrexate—hematologic cancer	1.59e-05	4.9e-05	CcSEcCtD
Ketorolac—Nausea—Etoposide—hematologic cancer	1.59e-05	4.89e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.59e-05	0.000254	CbGpPWpGaD
Ketorolac—Hypertension—Epirubicin—hematologic cancer	1.59e-05	4.89e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—HSP90AA1—hematologic cancer	1.59e-05	0.000254	CbGpPWpGaD
Ketorolac—Feeling abnormal—Prednisone—hematologic cancer	1.58e-05	4.87e-05	CcSEcCtD
Ketorolac—Asthenia—Dexamethasone—hematologic cancer	1.58e-05	4.86e-05	CcSEcCtD
Ketorolac—Asthenia—Betamethasone—hematologic cancer	1.58e-05	4.86e-05	CcSEcCtD
Ketorolac—Ill-defined disorder—Doxorubicin—hematologic cancer	1.58e-05	4.86e-05	CcSEcCtD
Ketorolac—Nervous system disorder—Methotrexate—hematologic cancer	1.57e-05	4.84e-05	CcSEcCtD
Ketorolac—Anaemia—Doxorubicin—hematologic cancer	1.57e-05	4.84e-05	CcSEcCtD
Ketorolac—Thrombocytopenia—Methotrexate—hematologic cancer	1.57e-05	4.83e-05	CcSEcCtD
Ketorolac—Gastrointestinal pain—Prednisone—hematologic cancer	1.57e-05	4.83e-05	CcSEcCtD
Ketorolac—Nausea—Prednisolone—hematologic cancer	1.57e-05	4.83e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.57e-05	0.000251	CbGpPWpGaD
Ketorolac—Myalgia—Epirubicin—hematologic cancer	1.57e-05	4.82e-05	CcSEcCtD
Ketorolac—Arthralgia—Epirubicin—hematologic cancer	1.57e-05	4.82e-05	CcSEcCtD
Ketorolac—Chest pain—Epirubicin—hematologic cancer	1.57e-05	4.82e-05	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—hematologic cancer	1.56e-05	4.81e-05	CcSEcCtD
Ketorolac—Anxiety—Epirubicin—hematologic cancer	1.56e-05	4.8e-05	CcSEcCtD
Ketorolac—Pruritus—Dexamethasone—hematologic cancer	1.56e-05	4.8e-05	CcSEcCtD
Ketorolac—Pruritus—Betamethasone—hematologic cancer	1.56e-05	4.8e-05	CcSEcCtD
Ketorolac—Skin disorder—Methotrexate—hematologic cancer	1.56e-05	4.79e-05	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.56e-05	4.78e-05	CcSEcCtD
Ketorolac—Hyperhidrosis—Methotrexate—hematologic cancer	1.55e-05	4.77e-05	CcSEcCtD
Ketorolac—Discomfort—Epirubicin—hematologic cancer	1.55e-05	4.76e-05	CcSEcCtD
Ketorolac—Vomiting—Triamcinolone—hematologic cancer	1.54e-05	4.75e-05	CcSEcCtD
Ketorolac—Malaise—Doxorubicin—hematologic cancer	1.53e-05	4.72e-05	CcSEcCtD
Ketorolac—Rash—Triamcinolone—hematologic cancer	1.53e-05	4.71e-05	CcSEcCtD
Ketorolac—Dry mouth—Epirubicin—hematologic cancer	1.53e-05	4.71e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—STAT1—hematologic cancer	1.53e-05	0.000245	CbGpPWpGaD
Ketorolac—Dermatitis—Triamcinolone—hematologic cancer	1.53e-05	4.71e-05	CcSEcCtD
Ketorolac—Vertigo—Doxorubicin—hematologic cancer	1.53e-05	4.7e-05	CcSEcCtD
Ketorolac—Anorexia—Methotrexate—hematologic cancer	1.53e-05	4.7e-05	CcSEcCtD
Ketorolac—Syncope—Doxorubicin—hematologic cancer	1.53e-05	4.7e-05	CcSEcCtD
Ketorolac—Urticaria—Prednisone—hematologic cancer	1.52e-05	4.69e-05	CcSEcCtD
Ketorolac—Leukopenia—Doxorubicin—hematologic cancer	1.52e-05	4.69e-05	CcSEcCtD
Ketorolac—Headache—Triamcinolone—hematologic cancer	1.52e-05	4.68e-05	CcSEcCtD
Ketorolac—Body temperature increased—Prednisone—hematologic cancer	1.52e-05	4.67e-05	CcSEcCtD
Ketorolac—Abdominal pain—Prednisone—hematologic cancer	1.52e-05	4.67e-05	CcSEcCtD
Ketorolac—Confusional state—Epirubicin—hematologic cancer	1.51e-05	4.66e-05	CcSEcCtD
Ketorolac—Diarrhoea—Betamethasone—hematologic cancer	1.51e-05	4.64e-05	CcSEcCtD
Ketorolac—Diarrhoea—Dexamethasone—hematologic cancer	1.51e-05	4.64e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.51e-05	0.000241	CbGpPWpGaD
Ketorolac—Palpitations—Doxorubicin—hematologic cancer	1.5e-05	4.63e-05	CcSEcCtD
Ketorolac—Oedema—Epirubicin—hematologic cancer	1.5e-05	4.62e-05	CcSEcCtD
Ketorolac—Anaphylactic shock—Epirubicin—hematologic cancer	1.5e-05	4.62e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.5e-05	0.00024	CbGpPWpGaD
Ketorolac—Hypotension—Methotrexate—hematologic cancer	1.5e-05	4.61e-05	CcSEcCtD
Ketorolac—Loss of consciousness—Doxorubicin—hematologic cancer	1.5e-05	4.6e-05	CcSEcCtD
Ketorolac—Infection—Epirubicin—hematologic cancer	1.49e-05	4.59e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—GSTP1—hematologic cancer	1.49e-05	0.000238	CbGpPWpGaD
Ketorolac—Cough—Doxorubicin—hematologic cancer	1.49e-05	4.57e-05	CcSEcCtD
Ketorolac—Shock—Epirubicin—hematologic cancer	1.48e-05	4.54e-05	CcSEcCtD
Ketorolac—Convulsion—Doxorubicin—hematologic cancer	1.47e-05	4.54e-05	CcSEcCtD
Ketorolac—Nervous system disorder—Epirubicin—hematologic cancer	1.47e-05	4.53e-05	CcSEcCtD
Ketorolac—Thrombocytopenia—Epirubicin—hematologic cancer	1.47e-05	4.52e-05	CcSEcCtD
Ketorolac—Hypertension—Doxorubicin—hematologic cancer	1.47e-05	4.52e-05	CcSEcCtD
Ketorolac—Tachycardia—Epirubicin—hematologic cancer	1.47e-05	4.51e-05	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.46e-05	4.5e-05	CcSEcCtD
Ketorolac—Skin disorder—Epirubicin—hematologic cancer	1.46e-05	4.49e-05	CcSEcCtD
Ketorolac—Dizziness—Dexamethasone—hematologic cancer	1.46e-05	4.48e-05	CcSEcCtD
Ketorolac—Dizziness—Betamethasone—hematologic cancer	1.46e-05	4.48e-05	CcSEcCtD
Ketorolac—Hyperhidrosis—Epirubicin—hematologic cancer	1.45e-05	4.46e-05	CcSEcCtD
Ketorolac—Insomnia—Methotrexate—hematologic cancer	1.45e-05	4.46e-05	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—hematologic cancer	1.45e-05	4.46e-05	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—hematologic cancer	1.45e-05	4.46e-05	CcSEcCtD
Ketorolac—Arthralgia—Doxorubicin—hematologic cancer	1.45e-05	4.46e-05	CcSEcCtD
Ketorolac—Anxiety—Doxorubicin—hematologic cancer	1.44e-05	4.44e-05	CcSEcCtD
Ketorolac—Nausea—Triamcinolone—hematologic cancer	1.44e-05	4.44e-05	CcSEcCtD
Ketorolac—Paraesthesia—Methotrexate—hematologic cancer	1.44e-05	4.43e-05	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.44e-05	4.43e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.44e-05	0.00023	CbGpPWpGaD
Ketorolac—PTGS2—Disease—GRB2—hematologic cancer	1.43e-05	0.000229	CbGpPWpGaD
Ketorolac—Discomfort—Doxorubicin—hematologic cancer	1.43e-05	4.4e-05	CcSEcCtD
Ketorolac—Anorexia—Epirubicin—hematologic cancer	1.43e-05	4.4e-05	CcSEcCtD
Ketorolac—Dyspnoea—Methotrexate—hematologic cancer	1.43e-05	4.4e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—PDGFA—hematologic cancer	1.43e-05	0.000229	CbGpPWpGaD
Ketorolac—Somnolence—Methotrexate—hematologic cancer	1.43e-05	4.39e-05	CcSEcCtD
Ketorolac—Dry mouth—Doxorubicin—hematologic cancer	1.42e-05	4.36e-05	CcSEcCtD
Ketorolac—Hypersensitivity—Prednisone—hematologic cancer	1.41e-05	4.35e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—NQO1—hematologic cancer	1.41e-05	0.000226	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CD44—hematologic cancer	1.41e-05	0.000226	CbGpPWpGaD
Ketorolac—Dyspepsia—Methotrexate—hematologic cancer	1.41e-05	4.34e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—KITLG—hematologic cancer	1.41e-05	0.000225	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ABCB1—hematologic cancer	1.41e-05	0.000225	CbGpPWpGaD
Ketorolac—Hypotension—Epirubicin—hematologic cancer	1.4e-05	4.32e-05	CcSEcCtD
Ketorolac—Vomiting—Dexamethasone—hematologic cancer	1.4e-05	4.31e-05	CcSEcCtD
Ketorolac—Vomiting—Betamethasone—hematologic cancer	1.4e-05	4.31e-05	CcSEcCtD
Ketorolac—Confusional state—Doxorubicin—hematologic cancer	1.4e-05	4.31e-05	CcSEcCtD
Ketorolac—Decreased appetite—Methotrexate—hematologic cancer	1.39e-05	4.29e-05	CcSEcCtD
Ketorolac—Rash—Dexamethasone—hematologic cancer	1.39e-05	4.28e-05	CcSEcCtD
Ketorolac—Rash—Betamethasone—hematologic cancer	1.39e-05	4.28e-05	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—hematologic cancer	1.39e-05	4.27e-05	CcSEcCtD
Ketorolac—Oedema—Doxorubicin—hematologic cancer	1.39e-05	4.27e-05	CcSEcCtD
Ketorolac—Dermatitis—Betamethasone—hematologic cancer	1.39e-05	4.27e-05	CcSEcCtD
Ketorolac—Dermatitis—Dexamethasone—hematologic cancer	1.39e-05	4.27e-05	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.38e-05	4.26e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.38e-05	0.000222	CbGpPWpGaD
Ketorolac—Fatigue—Methotrexate—hematologic cancer	1.38e-05	4.25e-05	CcSEcCtD
Ketorolac—Headache—Dexamethasone—hematologic cancer	1.38e-05	4.25e-05	CcSEcCtD
Ketorolac—Headache—Betamethasone—hematologic cancer	1.38e-05	4.25e-05	CcSEcCtD
Ketorolac—Infection—Doxorubicin—hematologic cancer	1.38e-05	4.25e-05	CcSEcCtD
Ketorolac—Asthenia—Prednisone—hematologic cancer	1.38e-05	4.24e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—STAT5A—hematologic cancer	1.38e-05	0.00022	CbGpPWpGaD
Ketorolac—Pain—Methotrexate—hematologic cancer	1.37e-05	4.22e-05	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.37e-05	4.21e-05	CcSEcCtD
Ketorolac—Shock—Doxorubicin—hematologic cancer	1.37e-05	4.2e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—NCOR1—hematologic cancer	1.36e-05	0.000219	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTM1—hematologic cancer	1.36e-05	0.000219	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN2B—hematologic cancer	1.36e-05	0.000218	CbGpPWpGaD
Ketorolac—Nervous system disorder—Doxorubicin—hematologic cancer	1.36e-05	4.19e-05	CcSEcCtD
Ketorolac—Thrombocytopenia—Doxorubicin—hematologic cancer	1.36e-05	4.18e-05	CcSEcCtD
Ketorolac—Pruritus—Prednisone—hematologic cancer	1.36e-05	4.18e-05	CcSEcCtD
Ketorolac—Insomnia—Epirubicin—hematologic cancer	1.36e-05	4.18e-05	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—hematologic cancer	1.36e-05	4.17e-05	CcSEcCtD
Ketorolac—Skin disorder—Doxorubicin—hematologic cancer	1.35e-05	4.15e-05	CcSEcCtD
Ketorolac—Paraesthesia—Epirubicin—hematologic cancer	1.35e-05	4.15e-05	CcSEcCtD
Ketorolac—Hyperhidrosis—Doxorubicin—hematologic cancer	1.34e-05	4.13e-05	CcSEcCtD
Ketorolac—Dyspnoea—Epirubicin—hematologic cancer	1.34e-05	4.12e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—CYCS—hematologic cancer	1.34e-05	0.000214	CbGpPWpGaD
Ketorolac—Somnolence—Epirubicin—hematologic cancer	1.33e-05	4.11e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—HSP90AA1—hematologic cancer	1.33e-05	0.000213	CbGpPWpGaD
Ketorolac—Anorexia—Doxorubicin—hematologic cancer	1.32e-05	4.07e-05	CcSEcCtD
Ketorolac—Feeling abnormal—Methotrexate—hematologic cancer	1.32e-05	4.07e-05	CcSEcCtD
Ketorolac—Dyspepsia—Epirubicin—hematologic cancer	1.32e-05	4.07e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—CD86—hematologic cancer	1.32e-05	0.000211	CbGpPWpGaD
Ketorolac—Diarrhoea—Prednisone—hematologic cancer	1.31e-05	4.04e-05	CcSEcCtD
Ketorolac—Gastrointestinal pain—Methotrexate—hematologic cancer	1.31e-05	4.04e-05	CcSEcCtD
Ketorolac—Nausea—Betamethasone—hematologic cancer	1.31e-05	4.03e-05	CcSEcCtD
Ketorolac—Nausea—Dexamethasone—hematologic cancer	1.31e-05	4.03e-05	CcSEcCtD
Ketorolac—Decreased appetite—Epirubicin—hematologic cancer	1.3e-05	4.01e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—HES1—hematologic cancer	1.3e-05	0.000208	CbGpPWpGaD
Ketorolac—Hypotension—Doxorubicin—hematologic cancer	1.3e-05	3.99e-05	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.3e-05	3.99e-05	CcSEcCtD
Ketorolac—Fatigue—Epirubicin—hematologic cancer	1.29e-05	3.98e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—NCOR1—hematologic cancer	1.29e-05	0.000207	CbGpPWpGaD
Ketorolac—Pain—Epirubicin—hematologic cancer	1.28e-05	3.95e-05	CcSEcCtD
Ketorolac—Constipation—Epirubicin—hematologic cancer	1.28e-05	3.95e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—FGF1—hematologic cancer	1.28e-05	0.000205	CbGpPWpGaD
Ketorolac—Urticaria—Methotrexate—hematologic cancer	1.27e-05	3.92e-05	CcSEcCtD
Ketorolac—Dizziness—Prednisone—hematologic cancer	1.27e-05	3.9e-05	CcSEcCtD
Ketorolac—Body temperature increased—Methotrexate—hematologic cancer	1.27e-05	3.9e-05	CcSEcCtD
Ketorolac—Abdominal pain—Methotrexate—hematologic cancer	1.27e-05	3.9e-05	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.27e-05	3.89e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—FOXO1—hematologic cancer	1.26e-05	0.000202	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PDGFRB—hematologic cancer	1.26e-05	0.000202	CbGpPWpGaD
Ketorolac—Insomnia—Doxorubicin—hematologic cancer	1.26e-05	3.86e-05	CcSEcCtD
Ketorolac—Paraesthesia—Doxorubicin—hematologic cancer	1.25e-05	3.84e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—PDGFRA—hematologic cancer	1.24e-05	0.000198	CbGpPWpGaD
Ketorolac—Dyspnoea—Doxorubicin—hematologic cancer	1.24e-05	3.81e-05	CcSEcCtD
Ketorolac—Feeling abnormal—Epirubicin—hematologic cancer	1.24e-05	3.81e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—PRKCG—hematologic cancer	1.23e-05	0.000198	CbGpPWpGaD
Ketorolac—PTGS2—Disease—JAK1—hematologic cancer	1.23e-05	0.000198	CbGpPWpGaD
Ketorolac—Somnolence—Doxorubicin—hematologic cancer	1.23e-05	3.8e-05	CcSEcCtD
Ketorolac—Gastrointestinal pain—Epirubicin—hematologic cancer	1.23e-05	3.78e-05	CcSEcCtD
Ketorolac—Dyspepsia—Doxorubicin—hematologic cancer	1.22e-05	3.76e-05	CcSEcCtD
Ketorolac—Vomiting—Prednisone—hematologic cancer	1.22e-05	3.75e-05	CcSEcCtD
Ketorolac—Rash—Prednisone—hematologic cancer	1.21e-05	3.72e-05	CcSEcCtD
Ketorolac—Dermatitis—Prednisone—hematologic cancer	1.21e-05	3.72e-05	CcSEcCtD
Ketorolac—Decreased appetite—Doxorubicin—hematologic cancer	1.21e-05	3.71e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—MTHFR—hematologic cancer	1.21e-05	0.000193	CbGpPWpGaD
Ketorolac—Headache—Prednisone—hematologic cancer	1.2e-05	3.7e-05	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.2e-05	3.69e-05	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—hematologic cancer	1.2e-05	3.68e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.2e-05	0.000192	CbGpPWpGaD
Ketorolac—Urticaria—Epirubicin—hematologic cancer	1.19e-05	3.67e-05	CcSEcCtD
Ketorolac—Constipation—Doxorubicin—hematologic cancer	1.19e-05	3.65e-05	CcSEcCtD
Ketorolac—Pain—Doxorubicin—hematologic cancer	1.19e-05	3.65e-05	CcSEcCtD
Ketorolac—Abdominal pain—Epirubicin—hematologic cancer	1.19e-05	3.65e-05	CcSEcCtD
Ketorolac—Body temperature increased—Epirubicin—hematologic cancer	1.19e-05	3.65e-05	CcSEcCtD
Ketorolac—Hypersensitivity—Methotrexate—hematologic cancer	1.18e-05	3.64e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—GSTP1—hematologic cancer	1.18e-05	0.000189	CbGpPWpGaD
Ketorolac—Asthenia—Methotrexate—hematologic cancer	1.15e-05	3.54e-05	CcSEcCtD
Ketorolac—Feeling abnormal—Doxorubicin—hematologic cancer	1.14e-05	3.52e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—MTHFR—hematologic cancer	1.14e-05	0.000183	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.14e-05	0.000183	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HLA-A—hematologic cancer	1.14e-05	0.000183	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TERT—hematologic cancer	1.14e-05	0.000183	CbGpPWpGaD
Ketorolac—Nausea—Prednisone—hematologic cancer	1.14e-05	3.51e-05	CcSEcCtD
Ketorolac—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.14e-05	3.49e-05	CcSEcCtD
Ketorolac—Pruritus—Methotrexate—hematologic cancer	1.13e-05	3.49e-05	CcSEcCtD
Ketorolac—PTGS2—Metabolism—ABCB1—hematologic cancer	1.12e-05	0.000179	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PDGFB—hematologic cancer	1.11e-05	0.000178	CbGpPWpGaD
Ketorolac—Hypersensitivity—Epirubicin—hematologic cancer	1.11e-05	3.4e-05	CcSEcCtD
Ketorolac—Urticaria—Doxorubicin—hematologic cancer	1.1e-05	3.39e-05	CcSEcCtD
Ketorolac—Body temperature increased—Doxorubicin—hematologic cancer	1.1e-05	3.38e-05	CcSEcCtD
Ketorolac—Abdominal pain—Doxorubicin—hematologic cancer	1.1e-05	3.38e-05	CcSEcCtD
Ketorolac—Diarrhoea—Methotrexate—hematologic cancer	1.1e-05	3.38e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—TSC2—hematologic cancer	1.09e-05	0.000174	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NCOR1—hematologic cancer	1.08e-05	0.000174	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTM1—hematologic cancer	1.08e-05	0.000174	CbGpPWpGaD
Ketorolac—Asthenia—Epirubicin—hematologic cancer	1.08e-05	3.31e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.06e-05	0.00017	CbGpPWpGaD
Ketorolac—Pruritus—Epirubicin—hematologic cancer	1.06e-05	3.27e-05	CcSEcCtD
Ketorolac—Dizziness—Methotrexate—hematologic cancer	1.06e-05	3.26e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—FGFR3—hematologic cancer	1.05e-05	0.000168	CbGpPWpGaD
Ketorolac—Diarrhoea—Epirubicin—hematologic cancer	1.03e-05	3.16e-05	CcSEcCtD
Ketorolac—Hypersensitivity—Doxorubicin—hematologic cancer	1.02e-05	3.15e-05	CcSEcCtD
Ketorolac—Vomiting—Methotrexate—hematologic cancer	1.02e-05	3.14e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—PIK3CG—hematologic cancer	1.01e-05	0.000162	CbGpPWpGaD
Ketorolac—Rash—Methotrexate—hematologic cancer	1.01e-05	3.11e-05	CcSEcCtD
Ketorolac—Dermatitis—Methotrexate—hematologic cancer	1.01e-05	3.11e-05	CcSEcCtD
Ketorolac—Headache—Methotrexate—hematologic cancer	1e-05	3.09e-05	CcSEcCtD
Ketorolac—Asthenia—Doxorubicin—hematologic cancer	9.97e-06	3.07e-05	CcSEcCtD
Ketorolac—Dizziness—Epirubicin—hematologic cancer	9.93e-06	3.05e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—BAD—hematologic cancer	9.92e-06	0.000159	CbGpPWpGaD
Ketorolac—Pruritus—Doxorubicin—hematologic cancer	9.83e-06	3.02e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—NOTCH1—hematologic cancer	9.82e-06	0.000157	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CD80—hematologic cancer	9.62e-06	0.000154	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KIT—hematologic cancer	9.61e-06	0.000154	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—MTHFR—hematologic cancer	9.58e-06	0.000153	CbGpPWpGaD
Ketorolac—Vomiting—Epirubicin—hematologic cancer	9.54e-06	2.94e-05	CcSEcCtD
Ketorolac—Nausea—Methotrexate—hematologic cancer	9.53e-06	2.93e-05	CcSEcCtD
Ketorolac—Diarrhoea—Doxorubicin—hematologic cancer	9.5e-06	2.92e-05	CcSEcCtD
Ketorolac—Rash—Epirubicin—hematologic cancer	9.47e-06	2.91e-05	CcSEcCtD
Ketorolac—Dermatitis—Epirubicin—hematologic cancer	9.46e-06	2.91e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—PTPN11—hematologic cancer	9.44e-06	0.000151	CbGpPWpGaD
Ketorolac—Headache—Epirubicin—hematologic cancer	9.4e-06	2.89e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CREBBP—hematologic cancer	9.4e-06	0.00015	CbGpPWpGaD
Ketorolac—Dizziness—Doxorubicin—hematologic cancer	9.19e-06	2.83e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—CREB1—hematologic cancer	9.14e-06	0.000146	CbGpPWpGaD
Ketorolac—PTGS2—Disease—BRAF—hematologic cancer	9.03e-06	0.000145	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6R—hematologic cancer	8.92e-06	0.000143	CbGpPWpGaD
Ketorolac—Nausea—Epirubicin—hematologic cancer	8.92e-06	2.74e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—PIK3CD—hematologic cancer	8.91e-06	0.000143	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CREBBP—hematologic cancer	8.91e-06	0.000143	CbGpPWpGaD
Ketorolac—Vomiting—Doxorubicin—hematologic cancer	8.83e-06	2.72e-05	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ALB—hematologic cancer	8.8e-06	0.000141	CbGpPWpGaD
Ketorolac—Rash—Doxorubicin—hematologic cancer	8.76e-06	2.69e-05	CcSEcCtD
Ketorolac—Dermatitis—Doxorubicin—hematologic cancer	8.75e-06	2.69e-05	CcSEcCtD
Ketorolac—Headache—Doxorubicin—hematologic cancer	8.7e-06	2.68e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—MAP2K1—hematologic cancer	8.5e-06	0.000136	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CD—hematologic cancer	8.45e-06	0.000135	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.44e-06	0.000135	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3R1—hematologic cancer	8.41e-06	0.000135	CbGpPWpGaD
Ketorolac—Nausea—Doxorubicin—hematologic cancer	8.25e-06	2.54e-05	CcSEcCtD
Ketorolac—PTGS2—Disease—FGF2—hematologic cancer	8.09e-06	0.000129	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CG—hematologic cancer	8.05e-06	0.000129	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3R1—hematologic cancer	7.98e-06	0.000128	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CB—hematologic cancer	7.77e-06	0.000124	CbGpPWpGaD
Ketorolac—PTGS2—Disease—JAK2—hematologic cancer	7.75e-06	0.000124	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MDM2—hematologic cancer	7.57e-06	0.000121	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CREBBP—hematologic cancer	7.46e-06	0.000119	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CB—hematologic cancer	7.36e-06	0.000118	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MTOR—hematologic cancer	7.36e-06	0.000118	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CD4—hematologic cancer	7.35e-06	0.000118	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CD—hematologic cancer	7.07e-06	0.000113	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALB—hematologic cancer	6.98e-06	0.000112	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1B—hematologic cancer	6.91e-06	0.000111	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTEN—hematologic cancer	6.71e-06	0.000107	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3R1—hematologic cancer	6.68e-06	0.000107	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—EP300—hematologic cancer	6.4e-06	0.000102	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1A—hematologic cancer	6.38e-06	0.000102	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PTEN—hematologic cancer	6.36e-06	0.000102	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CB—hematologic cancer	6.17e-06	9.87e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EP300—hematologic cancer	6.07e-06	9.71e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SRC—hematologic cancer	5.9e-06	9.45e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—STAT3—hematologic cancer	5.69e-06	9.11e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NRAS—hematologic cancer	5.68e-06	9.09e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MAPK3—hematologic cancer	5.44e-06	8.7e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PTEN—hematologic cancer	5.33e-06	8.53e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MYC—hematologic cancer	5.29e-06	8.47e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TGFB1—hematologic cancer	5.27e-06	8.44e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—EP300—hematologic cancer	5.08e-06	8.14e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KRAS—hematologic cancer	4.88e-06	7.82e-05	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CA—hematologic cancer	4.73e-06	7.58e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CA—hematologic cancer	4.49e-06	7.19e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HRAS—hematologic cancer	4.15e-06	6.65e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6—hematologic cancer	3.97e-06	6.36e-05	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AKT1—hematologic cancer	3.87e-06	6.19e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CA—hematologic cancer	3.76e-06	6.02e-05	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKT1—hematologic cancer	3.67e-06	5.87e-05	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AKT1—hematologic cancer	3.07e-06	4.92e-05	CbGpPWpGaD
